Follow on Google News News By Tag * Delivery * Drug * Oral * Parenteral * Devices * Therapeutic * Formulations * Novel * Platforms * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News | Study: Advanced Oral & Parenteral Drug Delivery Technologies Players, Products & Prospects to 2015Fast Market Research recommends "Advanced Oral & Parenteral Drug Delivery Technologies Players, Products & Prospects to 2015" from Espicom Business Intelligence, now available
Unique sales forecasts to 2015 for key technology areas Critical analyses of specialist developers driving the market onwards The increasing number of new biological products, and the emergence of a biosimilars market has focused the industry's attention on the development of novel and advanced drug delivery technologies which can deliver these new targeted products. However, oral and parenteral drug administration still dominates the market, and technical innovation is ensuring these tried and tested routes of administration continue to offer more compelling and effective methods of drug delivery. The global pharmaceutical industry generated revenues of over US$800 billion in 2009, growing at around 7% per annum. Oral formulations accounted for almost 60% of prescriptions, with the top 10 oral products accounting for nearly 10% of total global pharmaceutical sales. The global market for oral drug delivery enhanced products (DDEPs) was estimated to be worth around US$51 billion in 2009, accounting for nearly 60% of the market share of the entire DDEP market; sustained-release formulations represented over 95% of all oral DDEPs. Parenteral drug delivery is the second largest segment of the market accounting for nearly 30% of the market share. It is presently valued at US$27 billion and is expected to reach US$51 billion by 2015 driven primarily by the launch of new biologics; the uptake of novel delivery platforms and the utilisation of controlled-release systems. This report provides a detailed insight into the current and future market for oral and parenteral drug delivery technology, and... Provides an overview of the marketplace, outlining current thinking on the technologies being researched and employed Appraises currently available products which utilise advanced delivery platforms Examines new product developments from major specialist drug delivery companies, critically analysing their prospects Allows ready comparison on different technologies within a company's portfolio. Use this report to... Assess the strengths and weaknesses of competing products/technologies in the context of specific delivery sectors and development companies Identify and review licensing and collaborative partners Understand the merits and applications of the main approaches being researched. Quantify the commercial prospects for current and future products. Volume I Oral Delivery Technology During the last 30 years, considerable advances have been made in drug delivery technologies, particularly in the field of controlled-release delivery. However, there is an unremitting demand for products that achieve continuous release of therapeutic agents over extended time periods. This has led to the development of a multitude of drug delivery platforms mainly involving either multi-particulate dosage forms (e.g. pellets contained in gelatine capsules) or single-unit dosage forms (e.g. bilayer or multilayer tablets), and a variety of release profiles. Currently-marketed oral DDEPs encompass several therapeutic categories including cancer, cardiovascular, central nervous system, musculoskeletal, metabolic diseases (diabetes) and respiratory conditions. Oral disintegrating tablets (ODTs) or melts have evolved as an important delivery system for drugs that treat medical conditions vulnerable to a sudden onset of symptoms such as allergies, migraine, reflux disease and schizophrenia. In addition, oral DDEP platforms have been utilised to reduce the abuse-resistance of opioids and to prevent alcohol "dose dumping." Oral DDEPs are widely used across the globe as patients migrate towards convenient dosage formulations. Controlled-release tablets and capsules remain the main formulation platform although orally disintegrating, nanoparticle and combined technology formulations are expected to broaden applications in the future. Oral DDEPs use a variety of mechanisms to modify the controlled delivery of the molecule (drug) including: osmotic-driven drug release, degradation- A vigorous research environment Over 800 companies are currently involved in the development of oral drug delivery technologies from large pharma to specialty delivering technologists. This report identifies 29 of the top movers and shakers in the oral delivery industry. This report answer key questions What % of the oral drug delivery market by value do emerging markets account for? What is the current state of play with sustained, modified, chrono and pulsatile release technologies? What are the leading products that utilise advanced oral delivery and in what therapeutic areas are they most commonly applied? What research is being undertaken to develop novel drug delivery technologies for cancer? Will oral delivery technology ever crack the large molecule problem? Volume II Parenteral Delivery Technology For more information or to purchase this report, go to: - http://www.fastmr.com/ About Espicom Business Intelligence Espicom Business Intelligence is a highly-regarded and established provider of business intelligence services. Founded in 1982 as MDIS Publications Ltd, the company changed its name to Espicom in 1992. Initially a publisher in a wide range of industries such as power generation and telecommunications, they now focus on the global pharmaceutical and medical device sectors. View more research from Espicom Business Intelligence at http://www.fastmr.com/ About Fast Market Research Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156. # # # Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. End
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number